文章预览
以下由机器智能翻译,仅供参考。 1. Efficacy of subcutaneous sumatriptan in postcraniotomy pain and opioid consumption 皮下注射舒马曲坦对开颅术后疼痛和阿片类药物消耗的疗效 This study describes the efficacy of sumatriptan in the modulation of pain and opioid requirements following elective craniotomy surgery. The authors demonstrated that sumatriptan significantly reduces postoperative patient-reported pain scores at 6, 12, and 24 hours while also reducing the overall opioid requirements in both craniotomies and burr hole–type surgeries. Sumatriptan appears to be a safe and effective adjunct in postcraniotomy pain management in select patients, allowing for a reduction of postoperative opioid use. 这项研究描述了舒马曲坦在选择性开颅手术后调节疼痛和阿片类药物需求的功效。作者证明,舒马曲坦可显着降低术后6、12和24小时患者报告的疼痛评分,同时还降低了开颅手术和钻孔型手术
………………………………